Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$80.75 - $95.31 $306,850 - $362,178
-3,800 Reduced 33.04%
7,700 $622,000
Q2 2022

Aug 15, 2022

SELL
$87.4 - $113.09 $620,540 - $802,939
-7,100 Reduced 38.17%
11,500 $1.03 Million
Q1 2022

May 16, 2022

SELL
$100.58 - $112.38 $9.49 Million - $10.6 Million
-94,400 Reduced 83.54%
18,600 $2.06 Million
Q4 2021

Feb 14, 2022

BUY
$99.53 - $127.75 $8.68 Million - $11.1 Million
87,200 Added 337.98%
113,000 $11.7 Million
Q3 2021

Nov 15, 2021

BUY
$122.75 - $135.17 $2.95 Million - $3.24 Million
24,000 Added 1333.33%
25,800 $3.23 Million
Q1 2021

May 17, 2021

SELL
$111.18 - $119.74 $922,794 - $993,842
-8,300 Reduced 82.18%
1,800 $213,000
Q4 2020

Feb 16, 2021

BUY
$100.57 - $117.14 $1.02 Million - $1.18 Million
10,100 New
10,100 $1.18 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $113B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.